Disruption of an hTERT–mTOR–RAPTOR protein complex by a phytochemical perillyl alcohol and rapamycin

[1]  A. Galat.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands , 2013, Cellular and Molecular Life Sciences.

[2]  Dudley Lamming,et al.  Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2 , 2012, Front. Gene..

[3]  A. Schönthal,et al.  Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas , 2012, Molecular Cancer Therapeutics.

[4]  D. Gauthier,et al.  The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells , 2012, Biochimie.

[5]  Walid A Houry,et al.  The role of Hsp90 in protein complex assembly. , 2012, Biochimica et biophysica acta.

[6]  P. Hentosh,et al.  InTERTesting association between telomerase, mTOR and phytochemicals , 2012, Expert Reviews in Molecular Medicine.

[7]  A. Khan,et al.  Anticancer efficacy of perillyl alcohol-bearing PLGA microparticles , 2012, International journal of nanomedicine.

[8]  S. Shen,et al.  Inhibition of HSP90‐dependent telomerase activity in amyloid β‐induced apoptosis of cerebral endothelial cells , 2011, Journal of cellular physiology.

[9]  J. Fajkus,et al.  Non-telomeric activities of telomerase. , 2011, Molecular bioSystems.

[10]  T. Quirico-Santos,et al.  Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma , 2011, Journal of Cancer Research and Clinical Oncology.

[11]  D. Sabatini,et al.  Structure of the human mTOR complex I and its implications for rapamycin inhibition. , 2010, Molecular cell.

[12]  P. Bartels,et al.  A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer , 2010, Cancer Prevention Research.

[13]  M. Athar,et al.  Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. , 2009, Chemico-biological interactions.

[14]  N. Webster,et al.  Curcumin disrupts the Mammalian target of rapamycin-raptor complex. , 2009, Cancer research.

[15]  Greg M. Delgoffe,et al.  Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. , 2008, Molecular immunology.

[16]  A. Jimeno,et al.  Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  P. Fisher,et al.  Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis , 2008, Molecular Cancer Therapeutics.

[18]  T. Nakao,et al.  Pharmacogenomics of cardiovascular pharmacology: molecular network analysis in pleiotropic effects of statin -- an experimental elucidation of the pharmacologic action from protein-protein interaction analysis. , 2008, Journal of pharmacological sciences.

[19]  T. Quirico-Santos,et al.  Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. , 2007, Surgical neurology.

[20]  Barrie Wilkinson,et al.  Drug discovery beyond the 'rule-of-five'. , 2007, Current opinion in biotechnology.

[21]  R. Buechler,et al.  Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G interactions in human tumor cells. , 2007, Archives of biochemistry and biophysics.

[22]  Laurence H Pearl,et al.  Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. , 2006, Molecular cell.

[23]  A. Nakashima,et al.  Suppression of the mTOR-raptor signaling pathway by the inhibitor of heat shock protein 90 geldanamycin. , 2006, Journal of biochemistry.

[24]  W. Hahn,et al.  The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  O. Yamada,et al.  IL-2 Increases Human Telomerase Reverse Transcriptase Activity Transcriptionally and Posttranslationally through Phosphatidylinositol 3′-Kinase/Akt, Heat Shock Protein 90, and Mammalian Target of Rapamycin in Transformed NK Cells , 2005, The Journal of Immunology.

[26]  Sun-Mi Park,et al.  Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. , 2005, Genes & development.

[27]  R. Buechler,et al.  Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate‐mediated regulation of 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG‐CoA) reductase synthesis , 2004, Molecular carcinogenesis.

[28]  H. Mo,et al.  Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention , 2004, Experimental biology and medicine.

[29]  J. Avruch,et al.  Dissociation of raptor from mTOR is a mechanism of rapamycin‐induced inhibition of mTOR function , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[30]  G. Wilding,et al.  Phase I trial of perillyl alcohol administered four times daily continuously , 2003, Cancer Chemotherapy and Pharmacology.

[31]  J. Blenis,et al.  TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function , 2003, Current Biology.

[32]  J. Avruch,et al.  The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif* , 2003, The Journal of Biological Chemistry.

[33]  A. Zeiher,et al.  Regulation of telomerase activity and anti‐apoptotic function by protein–protein interaction and phosphorylation , 2003, FEBS letters.

[34]  J. Shay,et al.  Human Telomerase and Its Regulation , 2002, Microbiology and Molecular Biology Reviews.

[35]  J. Avruch,et al.  Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.

[36]  J. W. Turner,et al.  Stable Association of hsp90 and p23, but Not hsp70, with Active Human Telomerase* , 2001, The Journal of Biological Chemistry.

[37]  E. Blackburn,et al.  The end of the (DNA) line , 2000, Nature Structural Biology.

[38]  T. Tsuruo,et al.  Modulation of Akt kinase activity by binding to Hsp90. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Heitman,et al.  Antifungal Activities of Antineoplastic Agents:Saccharomyces cerevisiae as a Model System To Study Drug Action , 1999, Clinical Microbiology Reviews.

[40]  S. Do,et al.  Akt Protein Kinase Enhances Human Telomerase Activity through Phosphorylation of Telomerase Reverse Transcriptase Subunit* , 1999, The Journal of Biological Chemistry.

[41]  G. Morin,et al.  Functional requirement of p23 and Hsp90 in telomerase complexes. , 1999, Genes & development.

[42]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[43]  Stuart L. Schreiber,et al.  Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP , 1996, Science.

[44]  Paul Tempst,et al.  RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.

[45]  Carol W. Greider,et al.  The telomere terminal transferase of tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity , 1987, Cell.